4.6 Article

Interaction of Time-Varying Albumin and Phosphorus on Mortality in Incident Dialysis Patients

Journal

Publisher

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.03780411

Keywords

-

Funding

  1. Hans Drexel
  2. Austrian National Bank [13662]

Ask authors/readers for more resources

Background and objectives Hypoalbuminemia and hyperphosphatemia have been shown to be strong predictors of mortality in dialysis patients that might not be independent from each other. We prospectively investigated the relationship and interaction between serum albumin and phosphorus with all-cause mortality in an inception cohort of incident dialysis patients. Design, setting, participants, & measurements We followed 235 incident dialysis patients in a prospective single-center cohort study (INVOR study) applying a time-dependent Cox proportional hazards model using all measured laboratory values (2887 albumin and 10306 phosphorus values). Results Eighty-two patients (35%) died during a median follow-up of 35.1 months. Albumin was inversely associated with mortality (hazard ratio [95% confidence interval]: 0.23 [0.14 to 0.36]; P < 0.001), whereas higher phosphorus concentrations showed a trend to an increasing risk for mortality (hazard ratio 1.57 [95% confidence interval 0.97 to 2.54]; P = 0.07). Importantly, we observed a significant interaction between albumin and phosphorus (P = 0.01). The lowest risk was found with concurrent low phosphorus and high albumin values, whereas risk was increased with either concurrent low phosphorus and low albumin values or high phosphorus and high albumin values. Conclusions In incident dialysis patients the associations of serum phosphorus and albumin concentrations with mortality are modified by each other over time. Phosphorus-lowering interventions that concomitantly can cause a fall in serum albumin level may be harmful and warrant additional studies. If confirmed, epidemiologic studies and therapeutic guidelines aiming for target values should consider this interplay. Clin J Am Soc Nephrol 6: 2650-2656, 2011. doi: 10.2215/CJN.03780411

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Cis-epistasis at the LPA locus and risk of cardiovascular diseases

Lingyao Zeng, Sylvain Moser, Nazanin Mirza-Schreiber, Claudia Lamina, Stefan Coassin, Christopher P. Nelson, Tarmo Annilo, Oscar Franzen, Marcus E. Kleber, Salome Mack, Till F. M. Andlauer, Beibei Jiang, Barbara Stiller, Ling Li, Christina Willenborg, Matthias Munz, Thorsten Kessler, Adnan Kastrati, Karl-Ludwig Laugwitz, Jeanette Erdmann, Susanne Moebus, Markus M. Noethen, Annette Peters, Konstantin Strauch, Martina Mueller-Nurasyid, Christian Gieger, Thomas Meitinger, Elisabeth Steinhagen-Thiessen, Winfried Maerz, Andres Metspalu, Johan L. M. Bjoerkegren, Nilesh J. Samani, Florian Kronenberg, Bertram Mueller-Myhsok, Heribert Schunkert

Summary: This study attempts to identify non-additive genetic effects associated with CAD, specifically epistatic interactions. A SNP pair located in cis at the LPA locus was found to be jointly associated with risk for CAD, peripheral arterial disease, aortic stenosis, hepatic lipoprotein(a) levels, and Lp(a) serum levels, while individual SNPs displayed no association. Further exploration revealed a strong dependency on a rare variant influencing risk through additive genetic as well as epistatic effects.

CARDIOVASCULAR RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors

Valentin Blanchard, Kevin Chemello, Tim Hollstein, Clement Chong-Hong-Fong, Friederike Schumann, Thomas Grenkowitz, Brice Nativel, Stefan Coassin, Mikael Croyal, Ursula Kassner, Claudia Lamina, Elisabeth Steinhagen-Thiessen, Gilles Lambert

Summary: The size of apo(a) is an independent determinant of the response to PCSK9i, and each additional kringle domain is associated with a 3% additional reduction in Lp(a). This partly explains the variable efficacy of PCSK9i and allows for the identification of patients who will benefit most from these therapies in terms of Lp(a) lowering.

CARDIOVASCULAR RESEARCH (2022)

Article Medicine, General & Internal

Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events

Silvia Di Maio, Claudia Lamina, Stefan Coassin, Lukas Forer, Reinhard Wuerzner, Sebastian Schoenherr, Florian Kronenberg

Summary: The study found that SARS-CoV-2 infections enforce the association between high Lp(a) and IHD, but the risk for thromboembolic events is not influenced by Lp(a.

JOURNAL OF INTERNAL MEDICINE (2022)

Article Medicine, General & Internal

Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study

Johannes P. Schwaiger, Barbara Kollerits, Inga Steinbrenner, Hansi Weissensteiner, Sebastian Schoenherr, Lukas Forer, Fruzsina Kotsis, Claudia Lamina, Markus P. Schneider, Ulla T. Schultheiss, Christoph Wanner, Anna Koettgen, Kai-Uwe Eckardt, Florian Kronenberg

Summary: This study investigated the association between apoA-IV and all-cause mortality and cardiovascular outcomes in patients with CKD. The results showed that higher levels of apoA-IV were associated with lower inflammation levels and reduced risk of all-cause mortality, cardiovascular events, and heart failure.

JOURNAL OF INTERNAL MEDICINE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Measuring lipoprotein(a): do it without ifs and buts

Florian Kronenberg

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Article Medicine, General & Internal

Bariatric surgery prevents carotid wall thickness progression

Lukas Lunger, Andreas Melmer, Wolfgang Sturm, Claudia Lamina, Alexander Tschoner, Julia Engl, Armin Honlinger, Clemens Engler, Peter Willeit, Stefan Kiechl, Johann Willeit, Dietmar Ofner, Heinz Wykypiel, Markus Laimer, Herbert Tilg, Christoph Ebenbichler

Summary: The study demonstrates that weight loss induced by bariatric surgery can halt the natural progression of carotid intima media thickness (C-IMT) over a 10-year observation period, compared to a population-based control cohort.

WIENER KLINISCHE WOCHENSCHRIFT (2023)

Article Medical Laboratory Technology

Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests

L. Renee Ruhaak, Fred P. H. T. M. Romijn, Ilijana Begcevic Brkovic, Zsusanna Kuklenyik, Julia Dittrich, Uta Ceglarek, Andrew N. Hoofnagle, Harald Althaus, Eduardo Angles-Cano, Stefan Coassin, Vincent Delatour, Liesbet Deprez, Ioannis Dikaios, Gerhard M. Kostner, Florian Kronenberg, Alicia Lyle, Urban Prinzing, Hubert W. Vesper, Christa M. Cobbaert, Int Federation Clinical Chem Lab Med Working Grp Apolipoproteins Mass Spect

Summary: In order to ensure the accuracy and reliability of medical results from in vitro diagnostic and in-house tests, a higher order reference measurement system traceable to endorsed reference measurement procedures and reference materials is needed. A candidate reference measurement procedure for serum apolipoprotein(a) [apo(a)] based on mass spectrometry was developed and provisionally validated. The method demonstrated accurate quantitation of serum apo(a) and fulfilled predefined analytical performance specifications.

CLINICAL CHEMISTRY (2023)

Article Cardiac & Cardiovascular Systems

Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

Patrick B. Mark, Juan J. Carrero, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Josef Coresh, Aditya Surapaneni, Nigel J. Brunskill, John Chalmers, Lili Chan, Alex R. Chang, Rajkumar Chinnadurai, Gabriel Chodick, Massimo Cirillo, Dick de Zeeuw, Marie Evans, Amit X. Garg, Orlando M. Gutierrez, Hiddo J. L. Heerspink, Gunnar H. Heine, William G. Herrington, Junichi Ishigami, Florian Kronenberg, Jun Young Lee, Adeera Levin, Rupert W. Major, Angharad Marks, Girish N. Nadkarni, David M. J. Naimark, Christoph Nowak, Mahboob Rahman, Charumathi Sabanayagam, Mark Sarnak, Simon Sawhney, Markus P. Schneider, Varda Shalev, Jung-Im Shin, Moneeza K. Siddiqui, Nikita Stempniewicz, Keiichi Sumida, Jose M. Valdivielso, Jan van den Brand, Angela Yee-Moon Wang, David C. Wheeler, Lihua Zhang, Frank L. J. Visseren, Benedicte Stengel

Summary: This study investigated the association between cardiovascular disease (CVD) and future risk of kidney failure with replacement therapy (KFRT). It found that both prevalent and incident CVD were strongly associated with KFRT risk, with incident HF showing the strongest association.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Florian Kronenberg, Samia Mora, Erik S. G. Stroes, Brian A. Ference, Benoit J. Arsenault, Lars Berglund, Marc R. Dweck, Marlys L. Koschinsky, Gilles Lambert, Francois Mach, Catherine J. McNeal, Patrick M. Moriarty, Pradeep Natarajan, Borge G. Nordestgaard, Klaus G. Parhofer, Salim S. Virani, Arnold von Eckardstein, Gerald F. Watts, Jane K. Stock, Kausik K. Ray, Lale S. Tokgozoglu, Alberico L. Catapano

Summary: In 2022, the European Atherosclerosis Society (EAS) released a new consensus statement on the relationship between lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. This statement highlights the importance of understanding Lp(a) concentration and its impact on lifetime risk for ASCVD. It also provides practical advice on using Lp(a) concentration to manage risk factors, despite the lack of currently available targeted therapies to lower Lp(a).

ATHEROSCLEROSIS (2023)

Article Biochemistry & Molecular Biology

Haplogrep 3-an interactive haplogroup classification and analysis platform

Sebastian Schoenherr, Hansi Weissensteiner, Florian Kronenberg, Lukas Forer

Summary: This paper presents a major upgrade to the Haplogrep software, including added features such as haplogroup summary statistics and variant annotations from various genome databases, improved algorithms for large-scale data, and a new web framework. These improvements allow researchers to classify and investigate thousands of samples more conveniently.

NUCLEIC ACIDS RESEARCH (2023)

Article Medicine, General & Internal

Cardiovascular Risk Factor Control in 70-to 95-Year-Old Individuals: Cross-Sectional Results from the Population-Based AugUR Study

Ferdinand J. Donhauser, Martina E. Zimmermann, Anna B. Steinkirchner, Simon Wiegrebe, Alexander Dietl, Caroline Brandl, Ralph Burkhardt, Andre Gessner, Frank Schweda, Tobias Bergler, Elke Schaeffner, Carsten A. Boeger, Florian Kronenberg, Andreas Luchner, Klaus J. Stark, Iris M. Heid

Summary: Cardiovascular risk factors are common in old-aged individuals, but there is limited population-based data on their control in this population. The AugUR cohort study analyzed the cardiovascular risk factor control in the 70+-year-old population of/near Regensburg. The study found that a significant proportion of participants had high LDL-cholesterol, HbA1c, or blood pressure levels beyond recommended levels, and these factors were associated with impaired kidney function.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Pharmacology & Pharmacy

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor

Marlys L. Koschinsky, Erik S. G. Stroes, Florian Kronenberg

Summary: This review focuses on the causal association between Lipoprotein(a) (Lp(a)) and cardiovascular outcomes, the mechanisms by which elevated Lp(a) contributes to cardiovascular diseases, the metabolic insights on the production and clearance of Lp(a), and the current and future therapeutic approaches to lower Lp(a) concentrations.

PHARMACOLOGICAL RESEARCH (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Deep Learning Denoising of Low-Dose Computed Tomography Chest Images: A Quantitative and Qualitative Image Analysis

Lea Azour, Yunan Hu, Jane P. Ko, Baiyu Chen, Florian Knoll, Jeffrey B. Alpert, Geraldine Brusca-Augello, Derek M. Mason, Maj L. Wickstrom, Young Joon (Fred) Kwon, James Babb, Zhengrong Liang, William H. Moore

Summary: This study examined the deep learning denoised (DLD) computed tomography (CT) chest images at varying low doses using quantitative and qualitative perceptual image analysis. The results showed that DLD improved image quality quantitatively, but at doses of 10 mAs and below, the image quality was inferior to standard-dose images.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2023)

Article Biochemistry & Molecular Biology

Systemic Evidence for Mitochondrial Dysfunction in Age-Related Macular Degeneration as Revealed by mtDNA Copy Number Measurements in Peripheral Blood

Adriana Koller, Claudia Lamina, Caroline Brandl, Martina E. Zimmermann, Klaus J. Stark, Hansi Weissensteiner, Reinhard Wuerzner, Iris M. Heid, Florian Kronenberg, Jay Stewart

Summary: This study suggests that mtDNA copy number in blood may serve as a more accessible biomarker for age-related macular degeneration (AMD) than mtDNA copy number in the retina, providing new insights into the relationship between mtDNA-CN and AMD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Ophthalmology

Relative Telomere Length Is Associated With Age-Related Macular Degeneration in Women

Adriana Koller, Caroline Brandl, Claudia Lamina, Martina E. Zimmermann, Monika Summerer, Klaus J. Stark, Reinhard Wuerzner, Iris M. Heid, Florian Kronenberg

Summary: The study found an association between RTL and AMD restricted to women, which may be related to altered reactive oxygen species levels and higher telomerase activity in women. The results provide a clue to the gender-differential pathway for oxidative stress and AMD.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

No Data Available